211 related articles for article (PubMed ID: 17105234)
1. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.
Wu J; Guo Z
Bioconjug Chem; 2006; 17(6):1537-44. PubMed ID: 17105234
[TBL] [Abstract][Full Text] [Related]
2. Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidates.
Huo CX; Zheng XJ; Xiao A; Liu CC; Sun S; Lv Z; Ye XS
Org Biomol Chem; 2015 Mar; 13(12):3677-90. PubMed ID: 25679360
[TBL] [Abstract][Full Text] [Related]
3. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
[TBL] [Abstract][Full Text] [Related]
4. Synthetic and immunological studies of 5'-N-phenylacetyl sTn to develop carbohydrate-based cancer vaccines and to explore the impacts of linkage between carbohydrate antigens and carrier proteins.
Wang Q; Ekanayaka SA; Wu J; Zhang J; Guo Z
Bioconjug Chem; 2008 Oct; 19(10):2060-7. PubMed ID: 18816108
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients.
Adluri S; Helling F; Ogata S; Zhang S; Itzkowitz SH; Lloyd KO; Livingston PO
Cancer Immunol Immunother; 1995 Sep; 41(3):185-92. PubMed ID: 7553688
[TBL] [Abstract][Full Text] [Related]
6. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines.
Pan Y; Chefalo P; Nagy N; Harding C; Guo Z
J Med Chem; 2005 Feb; 48(3):875-83. PubMed ID: 15689172
[TBL] [Abstract][Full Text] [Related]
8. Preparation and immunological studies of protein conjugates of N -acylneuraminic acids.
Chefalo P; Pan Y; Nagy N; Harding C; Guo Z
Glycoconj J; 2004; 20(6):407-14. PubMed ID: 15238705
[TBL] [Abstract][Full Text] [Related]
9. A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm.
Ragupathi G; Koganty RR; Qiu D; Lloyd KO; Livingston PO
Glycoconj J; 1998 Mar; 15(3):217-21. PubMed ID: 9579798
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
11. Sialyl-Tn-KLH, glycoconjugate analysis and stability by high-pH anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD).
Jorge P; Abdul-Wajid A
Glycobiology; 1995 Dec; 5(8):759-64. PubMed ID: 8720073
[TBL] [Abstract][Full Text] [Related]
12. Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.
Zhang S; Walberg LA; Ogata S; Itzkowitz SH; Koganty RR; Reddish M; Gandhi SS; Longenecker BM; Lloyd KO; Livingston PO
Cancer Res; 1995 Aug; 55(15):3364-8. PubMed ID: 7614472
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.
MacLean GD; Reddish MA; Koganty RR; Longenecker BM
J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):59-68. PubMed ID: 8859725
[TBL] [Abstract][Full Text] [Related]
14. Synthetic and Immunological Studies of sTn Derivatives Carrying 5-N-(p-Substituted Phenylacetyl)Sialic Acid for the Development of Effective Cancer Vaccines.
Wang Q; Guo Z
ACS Med Chem Lett; 2011 May; 2(5):373-378. PubMed ID: 21691430
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn.
Kagan E; Ragupathi G; Yi SS; Reis CA; Gildersleeve J; Kahne D; Clausen H; Danishefsky SJ; Livingston PO
Cancer Immunol Immunother; 2005 May; 54(5):424-30. PubMed ID: 15625606
[TBL] [Abstract][Full Text] [Related]
16. Fluorine-modified sialyl-Tn-CRM197 vaccine elicits a robust immune response.
Song C; Zheng XJ; Guo H; Cao Y; Zhang F; Li Q; Ye XS; Zhou Y
Glycoconj J; 2019 Oct; 36(5):399-408. PubMed ID: 31267246
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.
Sun S; Zheng XJ; Huo CX; Song C; Li Q; Ye XS
ChemMedChem; 2016 May; 11(10):1090-6. PubMed ID: 27075633
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines.
Xiao A; Zheng XJ; Song C; Gui Y; Huo CX; Ye XS
Org Biomol Chem; 2016 Jul; 14(30):7226-37. PubMed ID: 27380866
[TBL] [Abstract][Full Text] [Related]
19. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
[TBL] [Abstract][Full Text] [Related]
20. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
Grigalevicius S; Chierici S; Renaudet O; Lo-Man R; Dériaud E; Leclerc C; Dumy P
Bioconjug Chem; 2005; 16(5):1149-59. PubMed ID: 16173792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]